Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer
Amirreza Mansoori-Kermani(Sharif University of Technology), Ebrahim Mostafavi(Cardiovascular Institute of the South), Iman Akbarzadeh(University of Technology Sydney), Fazeleh Ranjbar Niavol(Royan Institute), Athar Mahdieh(Tehran University of Medical Sciences), Sadaf Khalighi(Sharif University of Technology), Vahid Jahed(Riga Technical University), Yousef Fatahi(Tehran University of Medical Sciences), Alan Prem Kumar(National University of Singapore), Nima Ahmadkhani(Sharif University of Technology), Hamidreza Motasadizadeh(Tehran University of Medical Sciences), Masoud Abdinezhad(University of Tehran), Behnam Panahi(Sharif University of Technology), Nikoo Rahbariasr(Sharif University of Technology), Mahshid Hosseini(Sharif University of Technology), Masoud Mozafari(Iran University of Medical Sciences)
Cited by 77
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.8k
Overview of Silk Fibroin Use in Wound Dressings
|Trends in biotechnology|2018|465
Carbon Nanotubes: Smart Drug/Gene Delivery Carriers
|International Journal of Nanomedicine|2021|429
Fullerene: biomedical engineers get to revisit an old friend
|Materials Today|2017|363
Morbidity and mortality from road injuries: results from the Global Burden of Disease Study 2017
|Injury Prevention|2020|182